People aged 70 and up invited for repeat vaccination against COVID-19 People aged 70 years and older living in the Netherlands may receive an invitation for a repeat booster against COVID-19 from 26 February 2022 on. They can make an appointment for vaccination by the Municipal Public Health Services (GGDs).
Impact of coronavirus outbreak on participation in National Immunisation Programme limited Participation in the vaccinations against mumps, measles and rubella (MMR) and diphtheria, pertussis (whooping cough), tetanus and polio) (DTaP-IPV) has decreased slightly among infants (-1%).
Booster vaccination prevents many hospital and ICU admissions In the period from 26 January to 8 February 2022, the COVID-19 vaccines were 92% effective in preventing hospital admission after the booster, and 55% effective after the basic vaccinations.
Weekly vaccination figures per neighbourhood available through open data As of today, RIVM will publish weekly updates on vaccination turnout and vaccination coverage per neighbourhood in the Netherlands, both cumulative and broken down by calendar week.
Boosters improve diminished protection against Omicron infection after basic COVID-19 vaccination or previous infection Vaccination or previous infection with the coronavirus SARS-CoV-2 provide less effective protection against the Omicron variant compared to the Delta variant. A COVID-19 booster vaccination ensures renewed protection against Omicron.
Start cervical cancer screening on Saba February 7th 2022, a pilot for population screening for cervical cancer will start on Saba. All women between 30 and 60 years, will be invited to participate in the coming three years.
Joint Action CHRODIS PLUS: RIVM’s contribution to strengthening Health Promotion Within the Joint Action for the prevention and treatment of chronic diseases CHRODIS PLUS, RIVM has developed a set of recommendations for intersectoral cooperation to strengthen health promotion a
Report on the developments of the National Immunisation Programme: national immunisation coverage increased slightly for the first time in five years National immunisation coverage has increased for the first time in five years, for almost all vaccinations. For children born in 2017, vaccination coverage against mumps, measles and rubella (MMR) increased by 0.7% to 93.6%.
New data on antimicrobial resistance in Europe New data on antimicrobial resistance (AMR) in European countries is now available in the sixth annual report of the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) netw
International collaboration essential theme State of Zoonoses 2019 Each year, at the request of the Netherlands Food and Consumer Product Safety Authority, RIVM prepares an overview of the most important zoonoses and indicates their prevalence in the Netherlands.